title: Human receptor kinetics, tissue binding affinity, and stability of mometasone furoate.
abstract: Mometasone furoate (MF) is a topically used glucocorticoid with high anti-inflammatory potency. In contrast to the wealth of data derived from clinical studies, information about the molecular pharmacology of the compound is lacking or contradictory. Thus, we elucidated the characteristics of receptor binding kinetics and receptor affinity in a bioassay. Metabolite formation was determined in human plasma and lung tissue as well as binding affinity to human lung tissue. Fast and extensive association of MF to the human glucocorticoid receptor was observed while the dissociation of the MF-receptor complex was faster compared to fluticasone propionate (FP). The relative receptor affinity of MF was calculated as 2200 (dexamethasone = 100, FP = 1800) and confirmed in a bioassay measuring the induction of the glucocorticoid regulated protein CD163 in human monocytes. In plasma and human lung tissue MF formed a 9,11-epoxy degradation product. The binding affinity of MF to human lung tissue was low compared to FP due to fast redistribution from tissue into plasma. These molecular pharmacological properties are in accordance with clinical data.
authors.affiliation: Institut für Pharmazie und Lebensmittelchemie, Bayerische Julius-Maximilians-Universität, Am Hubland, 97074 Würzburg, Germany.
authors.forename: Anagnostis
authors.initials: A
authors.lastname: Valotis
authors.forename: Konrad
authors.initials: K
authors.lastname: Neukam
authors.forename: Olaf
authors.initials: O
authors.lastname: Elert
authors.forename: Petra
authors.initials: P
authors.lastname: Högger
mesh_terms: D015703:Antigens, CD / Q000096:biosynthesis / Q000378:metabolism; D015214:Antigens, Differentiation, Myelomonocytic / Q000096:biosynthesis / Q000378:metabolism; D001665:Binding Sites / Q000502:physiology; D001711:Biotransformation; D003600:Cytosol / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004355:Drug Stability; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D000068656:Mometasone Furoate; D009928:Organ Specificity / Q000502:physiology; D011244:Pregnadienediols / Q000097:blood / Q000737:chemistry* / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000096:biosynthesis / Q000378:metabolism; D011965:Receptors, Glucocorticoid / Q000378:metabolism*; D000098902:CD163 Antigen
chemical_list: D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D000098902:CD163 Antigen; D005938:Glucocorticoids; D018836:Inflammation Mediators; D011244:Pregnadienediols; D011956:Receptors, Cell Surface; D011965:Receptors, Glucocorticoid; D000068656:Mometasone Furoate